[Pathomechanism of amyloidosis development in the light of studies on transfer amyloidosis].
D000686:Amyloidosis / Q000139:chemically induced / Q000276:immunology*; D000818:Animals; D002364:Caseins / Q000008:administration & dosage / Q000009:adverse effects; D004195:Disease Models, Animal; D005246:Feedback; D006087:Graft vs Host Reaction; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007279:Injections, Subcutaneous; D051379:Mice; D013154:Spleen / Q000276:immunology
D002364:Caseins
Patomechanizm powstawania skrobiawicy w świetle badań nad przeniesiona amyloidoza "transfer amyloidosis"